Kohlberg Kravis Roberts & Co. L.P. HALOZYME THERAPEUTICS INC Transaction History

Kohlberg Kravis Roberts & Co. L.P.

  • $2.49 Billion
  • Q3 2025
Number of Shares
915,000
Previous 625,000 46.4%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
N/A
290,000 Added 46.4%
915,000 $0
Q1 2025

May 15, 2025
BUY
N/A
625,000 New
625,000 $0
Q3 2022

Nov 14, 2022
SELL
N/A
-4,000,000 Reduced 61.54%
2,500,000 $2.12 Million
Q2 2022

Aug 12, 2022
SELL
N/A
-500,000 Reduced 7.14%
6,500,000 $5.7 Million
Q1 2022

May 16, 2022
BUY
N/A
7,000,000 New
7,000,000 $6.19 Million
Track This Portfolio

Track Kohlberg Kravis Roberts & Co. L.P. Portfolio

Follow Kohlberg Kravis Roberts & Co. L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kohlberg Kravis Roberts & Co. L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kohlberg Kravis Roberts & Co. L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email